{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:14:51Z","timestamp":1792703691650,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jaci.2016.01.047","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T14:13:41Z","timestamp":1461939221000},"page":"536-543.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Investigation of peanut oral immunotherapy with CpG\/peanut nanoparticles in a murine model of peanut allergy"],"prefix":"10.1016","volume":"138","author":[{"given":"Kamal D.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Siefert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh A.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2016.01.047_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1399-3038.2008.00723.x","article-title":"Peanut and tree nut allergy in childhood","volume":"19","author":"Skripak","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.coi.2010.10.005","article-title":"Peanut allergy and anaphylaxis","volume":"22","author":"Finkelman","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1365-2222.2000.00889.x","article-title":"The psychological burden of peanut allergy as perceived by adults with peanut allergy\u00a0and the parents of peanut-allergic children","volume":"30","author":"Primeau","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.01.047_bib4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1398-9995.2008.01688.x","article-title":"Reported food allergy to peanut, tree nuts and fruit: comparison of clinical manifestations, prescription of medication and impact on daily life","volume":"63","author":"Le","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.01.047_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaci.2013.02.017","article-title":"Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison","volume":"132","author":"Chin","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2222.2011.03699.x","article-title":"Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome","volume":"41","author":"Anagnostou","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.01.047_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","article-title":"Oral peanut immunotherapy in children with peanut anaphylaxis","volume":"126","author":"Blumchen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2500\/aap.2013.34.3661","article-title":"Oral and sublingual peanut immunotherapy is not ready for general use","volume":"34","author":"Greenhawt","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2016.01.047_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2009.03.045","article-title":"Safety of a peanut oral immunotherapy protocol in children with peanut allergy","volume":"124","author":"Hofmann","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jaci.2009.09.042","article-title":"Adverse reactions during peanut oral immunotherapy home dosing","volume":"124","author":"Varshney","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4104\/pcrj.2011.00071","article-title":"Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies","volume":"21","author":"Sheikh","year":"2012","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaci.2016.01.047_bib13","first-page":"CD009014","article-title":"Allergen-specific oral immunotherapy for peanut allergy","volume":"9","author":"Nurmatov","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2016.01.047_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaip.2012.10.009","article-title":"Is peanut oral immunotherapy ready for use in clinical practice?","volume":"1","author":"Sampson","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2016.01.047_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v29.i2.20","article-title":"Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead","volume":"29","author":"Kumar","year":"2012","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.jaci.2016.01.047_bib16","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/nn405033r","article-title":"A\u00a0biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jaci.2016.01.047_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.vaccine.2014.12.059","article-title":"Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation","volume":"33","author":"Silva","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2016.01.047_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1749-6632.1998.tb09122.x","article-title":"Developing guidelines on the care and use of animals","volume":"862","author":"Bayne","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2016.01.047_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.anai.2012.03.008","article-title":"Efficacy and immunological actions of FAHF-2 in a murine model of multiple food allergies","volume":"108","author":"Srivastava","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/BF01311253","article-title":"Induced mucosal penetration and transfer to portal blood of luminal horseradish peroxidase after exposure of mucosa of guinea pig small intestine to ethanol and lysolecithin","volume":"29","author":"Talbot","year":"1984","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2016.01.047_bib21","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.biomaterials.2005.02.025","article-title":"Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting","volume":"26","author":"Fahmy","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jaci.2016.01.047_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0076-6879(10)80005-9","article-title":"Microbe-associated molecular patterns in innate immunity: extraction and chemical analysis of gram-negative bacterial lipopolysaccharides","volume":"480","author":"De Castro","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jaci.2016.01.047_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1067\/mai.2000.107395","article-title":"A\u00a0murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses","volume":"106","author":"Li","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2004.10.003","article-title":"The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy","volume":"115","author":"Srivastava","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1365-2222.2007.02718.x","article-title":"Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma","volume":"37","author":"Qu","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.01.047_bib26","doi-asserted-by":"crossref","first-page":"e28917","DOI":"10.1371\/journal.pone.0028917","article-title":"Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses","volume":"6","author":"Smit","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2016.01.047_bib27","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2016.01.047_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejpb.2013.03.003","article-title":"Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB\/c mice","volume":"85","author":"Pali-Scholl","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jaci.2016.01.047_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/IJN.S40579","article-title":"Concepts and practices used to develop functional PLGA-based nanoparticulate systems","volume":"8","author":"Sah","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jaci.2016.01.047_bib30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mnfr.201200410","article-title":"Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice","volume":"57","author":"Kulis","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jaci.2016.01.047_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/thoraxjnl-2013-204605","article-title":"A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice","volume":"69","author":"Campbell","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2016.01.047_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mai.2002.126660","article-title":"Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity","volume":"110","author":"Horner","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mai.2000.107933","article-title":"DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice","volume":"106","author":"Horner","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaci.2004.03.003","article-title":"Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA","volume":"113","author":"Simons","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2222.2008.03191.x","article-title":"Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I\/IIa clinical trial","volume":"39","author":"Senti","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.01.047_bib36","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa052916","article-title":"Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis","volume":"355","author":"Creticos","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.01.047_bib37","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1172\/JCI200316142","article-title":"Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts","volume":"111","author":"Turcanu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2016.01.047_bib38","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.4049\/jimmunol.1000768","article-title":"TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis","volume":"185","author":"Demento","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib39","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jaci.2012.04.009","article-title":"Oral immunotherapy induces local protective mechanisms in the gastrointestinal mucosa","volume":"129","author":"Leonard","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib40","doi-asserted-by":"crossref","first-page":"13195","DOI":"10.1021\/jf202963r","article-title":"Immunomodulatory effects of heated ovomucoid-depleted egg white in a BALB\/c mouse model of egg allergy","volume":"59","author":"Jimenez-Saiz","year":"2011","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jaci.2016.01.047_bib41","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jaci.2014.05.042","article-title":"Oral immunotherapy induces IgG antibodies that act through FcgammaRIIb to suppress IgE-mediated hypersensitivity","volume":"134","author":"Burton","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.047_bib42","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1211\/jpp.58.6.0004","article-title":"Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses","volume":"58","author":"Lutsiak","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jaci.2016.01.047_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1567201043334597","article-title":"Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery","volume":"1","author":"Diwan","year":"2004","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.jaci.2016.01.047_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2013.03.010","article-title":"Immune system targeting by biodegradable nanoparticles for cancer vaccines","volume":"168","author":"Silva","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.jaci.2016.01.047_bib45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1398-9995.2011.02777.x","article-title":"Immunotherapy with oligomannose-coated liposomes ameliorates allergic symptoms in a murine food allergy model","volume":"67","author":"Kawakita","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.01.047_bib46","doi-asserted-by":"crossref","first-page":"e31967","DOI":"10.1371\/journal.pone.0031967","article-title":"Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice","volume":"7","author":"Mondoulet","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2016.01.047_bib47","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/alr.20074","article-title":"Desensitizing mice to ovalbumin through subcutaneous microsphere immunotherapy (SMITH)","volume":"1","author":"Reisacher","year":"2011","journal-title":"Int Forum Allergy Rhinol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916004504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916004504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:57:57Z","timestamp":1758790677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674916004504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0091674916004504"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2016.01.047","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of peanut oral immunotherapy with CpG\/peanut nanoparticles in a murine model of peanut allergy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2016.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}